from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3865/espF

LFCtreatmentdescriptionclass of inhibitor

-1.085

Amikacinug/mL Amikacintranslation

-1.470

Cap5-10ug/mL Capreomycintranslation

-1.343

Rox10-50 ug/mL Roxithromycintranslation

0.371

SM2-5 ug/mL Streptomycintranslation

-2.824

Tet5-10 ug/mL Tetracyclinetranslation

-0.889

Rif0.2-5ug/mL Rifampicintranscription

-0.372

Rifp0.1-0.5ug/mL Rifapentinetranscription

0.632

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

1.633

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

1.054

CPZ10-50 ug/mL Chlorpromazinerespiration

0.854

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.091

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

1.413

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

2.070

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.776

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

0.036

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.831

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.457

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.184

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.893

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.333

KCN5-20 ug/mL Potassium cyaniderespiration

0.451

NaN30.2-2 mM Sodium aziderespiration

1.093

Nigericin50 uM Nigericinrespiration

1.733

TRC10-150 ug/mL Triclosanrespiration

0.771

TRZ10-25 ug/mL Thioridazinerespiration

1.777

Valinomycin0.5-10 uM Valinomycinrespiration

-0.422

ZnSO42 mM ZnSO4respiration

0.488

menadione6-10 ug/mL Menadionerespiration

0.338

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.631

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.111

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.499

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.023

NRP_1Non-replicating persistence stage 1dosRassociated

-0.234

Amp0.2mg/mL AmpicillincellWall

-0.457

Cephalexin20-100 ug/mL CephalexincellWall

-0.213

Cerulenin0.32-5 ug/mL CerulenincellWall

0.093

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.172

EMB10-20 ug/mL EthambutolcellWall

-0.251

Eta12-40 ug/mL EthionamidecellWall

-0.333

INH0.2-0.4 ug/mL IsoniazidcellWall

-0.430

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.279

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.699

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.698

BZA0.12 mg/mL BenzamidearomaticAmides

0.183

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.143

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-1.467

H2O24 mM hydrogen peroxideDNAdamaging

-0.323

Levo10 ug/mL LevofloxacinDNAdamaging

-1.334

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

1.714

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.507

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.836

UVUV-irradiationDNAdamaging

0.383

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.416

Antimycin12.5-50 ug/mL Antimycin A?

-0.177

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.090

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.393

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.226

PA8240.2-2 ug/mL PA-824?

0.198

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.222

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.143

Verapamil50 uM Verapamil?

-0.004

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.665

methoxatin10-20 ug/mL Methoxatin?